As partners of our internationally operating clients, we support the successful market access especially of treatments for rare diseases, of ATMPs or of products which set new therapy standards, both on a strategic and operational level. We dedicate our enthusiasm to solving complex problems.
Digital Health Applications (DiGAs) - the path to reimbursement
With our longstanding AMNOG-expertise we support DiGA-providers with a customized market access strategy – all the way from the development of the value story to successful price negotiations.